Gender Differences in Antihypertensive Treatment: Myths or Legends?
暂无分享,去创建一个
Massimo Salvetti | M. Muiesan | M. Salvetti | A. Paini | Anna Paini | C. A. Rosei | Maria Lorenza Muiesan | Claudia Agabiti Rosei
[1] Peter Sleight,et al. Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial. , 2003, JAMA.
[2] C. Lewis,et al. Long-Term Effects on Sexual Function of Five Antihypertensive Drugs and Nutritional Hygienic Treatment in Hypertensive Men and Women: Treatment of Mild Hypertension Study (TOMHS) , 1998 .
[3] R. Facchetti,et al. Menopause-related blood pressure increase and its relationship to age and body mass index: the SIMONA epidemiological study , 2005, Journal of hypertension.
[4] C. Crandall,et al. Health information on the Internet: how will it affect patient care? , 2000, The journal of gender-specific medicine : JGSM : the official journal of the Partnership for Women's Health at Columbia.
[5] E. O’Brien,et al. Ambulatory Blood Pressure Monitoring in 9357 Subjects From 11 Populations Highlights Missed Opportunities for Cardiovascular Prevention in Women , 2011, Hypertension.
[6] B. Davis,et al. Stroke outcomes among participants randomized to chlorthalidone, amlodipine or lisinopril in ALLHAT. , 2014, Journal of the American Society of Hypertension : JASH.
[7] J. Cutler,et al. Treatment of Mild Hypertension Study. Final results. Treatment of Mild Hypertension Study Research Group. , 1993, JAMA.
[8] T. Kahan,et al. Treatment of mild to moderate hypertension by gender perspective: a systematic review. , 2009, Journal of women's health.
[9] S. Oparil,et al. Gender and Blood Pressure , 2005, Journal of clinical hypertension.
[10] S. Kjeldsen,et al. Influence of gender on prevention of myocardial infarction by antihypertensives and acetylsalicylic acid: the HOT study. , 2000, The journal of gender-specific medicine : JGSM : the official journal of the Partnership for Women's Health at Columbia.
[11] E. Seely,et al. Estradiol with or without progesterone and ambulatory blood pressure in postmenopausal women. , 1999, Hypertension.
[12] Thomas Kahan,et al. Gender differences in antihypertensive drug treatment: results from the Swedish Primary Care Cardiovascular Database (SPCCD). , 2014, Journal of the American Society of Hypertension : JASH.
[13] R. Kloner,et al. Sex- and age-related antihypertensive effects of amlodipine , 1996 .
[14] D. Mozaffarian,et al. Heart disease and stroke statistics--2011 update: a report from the American Heart Association. , 2011, Circulation.
[15] J. Staessen,et al. The epidemiology of the association between hypertension and menopause , 1998, Journal of Human Hypertension.
[16] I. Paakkari,et al. Randomized comparison between orally and transdermally administered hormone replacement therapy regimens of long-term effects on 24-hour ambulatory blood pressure in postmenopausal women. , 2001, American journal of obstetrics and gynecology.
[17] T. Hedner,et al. Influence of age, sex and blood pressure on the principal endpoints of the Nordic Diltiazem (NORDIL) Study , 2002, Journal of hypertension.
[18] J. Cutler,et al. Effect of Antihypertensive Drug Treatment on Cardiovascular Outcomes in Women and Men , 1997, Annals of Internal Medicine.
[19] N. Wenger,et al. Management of hypertension in women , 2012, Hypertension Research.
[20] Mark D. Huffman,et al. AHA Statistical Update Heart Disease and Stroke Statistics — 2012 Update A Report From the American Heart Association WRITING GROUP MEMBERS , 2010 .
[21] K. Lindley,et al. Dissecting the Dilemma: Uncontrolled Hypertension in a Pregnant Patient. , 2016, The American journal of medicine.
[22] B. Cengiz,et al. Long-term effects of low-dose 17β-estradiol plus dydrogesterone on 24-h ambulatory blood pressure in healthy postmenopausal women: A 1-year, randomized, prospective study , 2007 .
[23] I. Milsom,et al. Transdermal oestrogen reduces daytime blood pressure in hypertensive women , 1998, Journal of Human Hypertension.
[24] J. Mehta,et al. Effect of Joint National Committee VII report on hospitalizations for hypertensive emergencies in the United States. , 2011, The American journal of cardiology.
[25] C. Pepine,et al. A calcium antagonist vs. a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease: the international verapamil-trandolapril study (INVEST): a randomized controlled trial , 2004 .
[26] M. Salvetti,et al. Gender Differences in Regression of Electrocardiographic Left Ventricular Hypertrophy During Antihypertensive Therapy , 2008 .
[27] S. Tretli,et al. Female preponderance for lisinopril-induced cough in hypertension. , 1994, American journal of hypertension.
[28] Peter Scarborough,et al. Cardiovascular disease in Europe--epidemiological update 2015. , 2015, European heart journal.
[29] P. August. Hypertension in women. , 2013, Advances in chronic kidney disease.
[30] P. Okin,et al. Gender Differences in Regression of Electrocardiographic Left Ventricular Hypertrophy During Antihypertensive Therapy , 2008, Hypertension.
[31] Jacob C. Seidell,et al. Sex differences in the pharmacological treatment of hypertension: a review of population‐based studies , 1997, Journal of hypertension.
[32] R. Cífková,et al. Blood pressure around the menopause: a population study , 2008, Journal of hypertension.
[33] M. Barton,et al. Postmenopausal hypertension: mechanisms and therapy. , 2009, Hypertension.
[34] C. Lewis,et al. Treatment of Mild Hypertension Study: Final Results , 1993 .
[35] Jeroen J. Bax,et al. 2007 ESH-ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). , 2007, Blood pressure.
[36] Peter Scarborough,et al. Cardiovascular disease in Europe: epidemiological update. , 2014, European heart journal.
[37] M. Muiesan,et al. Sex differences in hypertension-related renal and cardiovascular diseases in Italy: the I-DEMAND study , 2012, Journal of hypertension.
[38] Rowena J Dolor,et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the American Heart Association. , 2011, Journal of the American College of Cardiology.
[39] A. Høieggen,et al. Hypertension in women: latest findings and clinical implications , 2012, Therapeutic advances in chronic disease.
[40] J. Manson,et al. The effect of hormone therapy on mean blood pressure and visit-to-visit blood pressure variability in postmenopausal women: results from the Women's Health Initiative randomized controlled trials , 2014, Journal of hypertension.
[41] B. Davis,et al. Mortality and Morbidity During and After Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial: Results by Sex , 2013, Hypertension.
[42] J. Seidell,et al. Sex differences in antihypertensive drug use: determinants of the choice of medication for hypertension , 1998, Journal of hypertension.
[43] S. Oparil,et al. Effects of Losartan in Women With Hypertension and Left Ventricular Hypertrophy: Results From the Losartan Intervention For Endpoint Reduction in Hypertension Study , 2008, Hypertension.
[44] J. Laragh,et al. Outcomes in subgroups of hypertensive patients treated with regimens based on valsartan and amlodipine: an analysis of findings from the VALUE trial , 2006, Journal of hypertension.
[45] Peter Sleight,et al. Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial. , 2003 .
[46] A. Dyer,et al. Impact of Blood Pressure and Blood Pressure Change During Middle Age on the Remaining Lifetime Risk for Cardiovascular Disease: The Cardiovascular Lifetime Risk Pooling Project , 2012, Circulation.
[47] Peter Scarborough,et al. Cardiovascular disease in Europe 2015: epidemiological update. , 2015, European heart journal.
[48] M. Woodward,et al. Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials. , 2008, European heart journal.
[49] Jackson T. Wright,et al. A Randomized Trial of Intensive versus Standard Blood-Pressure Control. , 2016, The New England journal of medicine.
[50] M. Woodward,et al. Prevalence, Awareness, Treatment, and Control of Hypertension in China: Data from the China National Nutrition and Health Survey 2002 , 2008, Circulation.
[51] Heather M. Tavel,et al. Age-dependent gender differences in hypertension management , 2011, Journal of hypertension.
[52] A. Dominiczak,et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) , 2007, European heart journal.
[53] R. Herings,et al. Differences in antihypertensive drug persistence associated with drug class and gender: a PHARMO study , 2005, Pharmacoepidemiology and drug safety.
[54] R. Ferriani,et al. Low-dose transdermal hormone therapy does not interfere with the blood pressure of hypertensive menopausal women: a pilot study , 2008, Blood pressure monitoring.
[55] V. Tikhonoff,et al. Menopause does not affect blood pressure and risk profile, and menopausal women do not become similar to men , 2008, Journal of hypertension.
[56] G. Mancia,et al. Factors involved in the discontinuation of antihypertensive drug therapy: an analysis from real life data , 2014, Journal of hypertension.
[57] L. Ghiadoni,et al. Menopause is associated with endothelial dysfunction in women. , 1996, Hypertension.
[58] S. Majumdar,et al. Antihypertensive medications, bone mineral density, and fractures: a review of old cardiac drugs that provides new insights into osteoporosis , 2014, Endocrine.
[59] G. Mancia,et al. Blood pressure levels and control in Italy: comprehensive analysis of clinical data from 2000–2005 and 2005–2011 hypertension surveys , 2015, Journal of Human Hypertension.
[60] P. Kirchhof,et al. The task force for the management ofarterial hypertension of the european society ofhypertension (esh) and of the european society of cardiology (esc) , 2013 .
[61] IferganeGal,et al. Stroke Hospitalizations Over Three Decades: Lower for Men, Unchanged for Women. A Population-Based Study , 2014 .
[62] O. Hanon,et al. Treatment With Multiple Blood Pressure Medications, Achieved Blood Pressure, and Mortality in Older Nursing Home Residents: The PARTAGE Study. , 2015, JAMA internal medicine.
[63] Michael Böhm,et al. Antihypertensive drug therapy and blood pressure control in men and women: an international perspective , 2010, Journal of Human Hypertension.
[64] W. Callaghan,et al. Hypertension in Women of Reproductive Age in the United States: NHANES 1999-2008 , 2012, PloS one.
[65] R. Kloner,et al. Sex- and age-related antihypertensive effects of amlodipine. The Amlodipine Cardiovascular Community Trial Study Group. , 1996, The American journal of cardiology.
[66] B. Davis,et al. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). , 2002, JAMA.
[67] K. Schenck-Gustafsson,et al. Gender in cardiovascular diseases: impact on clinical manifestations, management, and outcomes. , 2016, European heart journal.
[68] Jing Chen,et al. Prevalence, Awareness, Treatment, and Control of Hypertension in China , 2002, Hypertension.